Results 41 to 50 of about 98,103 (155)

Detection of multidrug resistant Mycobacterium tuberculosis in Tabuk, Saudi Arabia, using Genotype MTBDRplus

International Journal of Mycobacteriology, 2019
Background: The global increase in the rates of multidrug-resistant (MDR) tuberculosis (TB) has made the timely identification of resistant Mycobacterium tuberculosis complex strains an important emergence to achieve effective disease management and to ...
Eltayib Hassan Ahmed-Abakur, Tarig Mohammed Saad Alnour   +1 more
doaj   +1 more source

Multi-Fluorescence Real-Time PCR Assay for Detection of RIF & INH Resistance of M. tuberculosis

Frontiers in Microbiology, 2016
Background: Failure to early detect multidrug-resistant tuberculosis (MDR-TB) results in treatment failure and poor clinical outcomes, and highlights the need to rapidly detect resistance to rifampicin (RIF) and isoniazid (INH)Methods: In Multi ...
Jingfu ePeng, Xiaoli eYu, Zhenglin eCui, Wenfei eXue, Ziyi eLuo, Zilu eWen, Minghua eLiu, Danqing eJiang, Heping eZheng, Hai eWu, Shulin eZhang, Yao eLi   +11 more
doaj   +1 more source

Impact of COVID-19 pandemic on tuberculosis [PDF]

Medical Laboratory Journal
Background: Tuberculosis (TB) is a disease of the respiratory system that spreads when a patient coughs, sneezes, or spits. COVID-19, another respiratory disease, created havoc in 2020 and 2021.
Sae Pol, Pooja Shah, Vaishali Gaikwad, Sujata Dharmshale, Mansi Rajmane, Rajesh Karyakarte   +5 more
doaj  

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections [PDF]

Universa Medicina, 2009
The increased percentage of patients with HIV-TB coinfection leads to inevitable interactions between rifampicin and efavirenz. Efavirenz is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV infection.
Yenny
doaj  

Dinucleotide codon substitutions as a signature of diversifying selection in Mycobacterium tuberculosis

Frontiers in Molecular Biosciences
The evolution of the human pathogen Mycobacterium tuberculosis is shaped by various but interconnected processes of drug treatment pressure and host adaptation.
Danila Zimenkov, Anastasia Ushtanit
doaj   +1 more source

Corynebacterium striatum‐Associated Pyogenic Osteomyelitis With Direct Extension From Postoperative Empyema

Respirology Case Reports
Corynebacterium striatum can cause postoperative empyema. C. striatum‐associated empyema may be associated with osteomyelitis. Rifampicin is a viable therapeutic option for C. striatum infection.
Shinnosuke Fukushima, Kazuhiro Noma, Hideharu Hagiya   +2 more
doaj   +1 more source

Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine

Molecules
Tuberculosis (TB) remains one of the leading global causes of mortality. Several methods have been established to detect anti-TB agents in human plasma and serum. However, there is a notable absence of studies analyzing TB drugs in urine.
Mohamed Abouzid, Katarzyna Kosicka-Noworzyń, Marta Karaźniewicz-Łada, Prakruti Rao, Nisha Modi, Yingda L. Xie, Scott K. Heysell, Anna Główka, Leonid Kagan   +8 more
doaj   +1 more source

RIFAMPICIN AND THROMBOCYTOPENIA [PDF]

Medical Journal of Australia, 1970
openaire   +2 more sources

Synergy and rifampicin [PDF]

Journal of Antimicrobial Chemotherapy, 1977
openaire   +2 more sources

A case of treatment for pulmonary infection caused by multidrug‐resistant Acinetobacter baumannii

Respirology Case Reports
Acinetobacter baumannii is a major pathogen in hospital‐acquired infections notorious for its strong acquired resistance and complex drug resistance mechanisms.
Chenxia Guo, Shaohua Xu, Wei Yan
doaj   +1 more source